These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21566148)

  • 1. Phosphonoformic acid inhibits viral replication by trapping the closed form of the DNA polymerase.
    Zahn KE; Tchesnokov EP; Götte M; Doublié S
    J Biol Chem; 2011 Jul; 286(28):25246-55. PubMed ID: 21566148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
    Piret J; Goyette N; Eckenroth BE; Drouot E; Götte M; Boivin G
    J Virol; 2015 Apr; 89(8):4636-44. PubMed ID: 25673718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering of a chimeric RB69 DNA polymerase sensitive to drugs targeting the cytomegalovirus enzyme.
    Tchesnokov EP; Obikhod A; Schinazi RF; Götte M
    J Biol Chem; 2009 Sep; 284(39):26439-46. PubMed ID: 19622750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of helix P of the human cytomegalovirus DNA polymerase in resistance and hypersusceptibility to the antiviral drug foscarnet.
    Tchesnokov EP; Gilbert C; Boivin G; Götte M
    J Virol; 2006 Feb; 80(3):1440-50. PubMed ID: 16415021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Amino Acid Substitutions in Region II and Helix K of Herpes Simplex Virus 1 and Human Cytomegalovirus DNA Polymerases on Resistance to Foscarnet.
    Zarrouk K; Zhu X; Pham VD; Goyette N; Piret J; Shi R; Boivin G
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0039021. PubMed ID: 33875432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Acyclovir, Foscarnet, and Ribonucleotides on Herpes Simplex Virus-1 DNA Polymerase: Mechanistic Insights and a Novel Mechanism for Preventing Stable Incorporation of Ribonucleotides into DNA.
    Vashishtha AK; Kuchta RD
    Biochemistry; 2016 Feb; 55(7):1168-77. PubMed ID: 26836009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point mutations induced by foscarnet (PFA) in the human cytomegalovirus DNA polymerase.
    Mousavi-Jazi M; Schloss L; Wahren B; Brytting M
    J Clin Virol; 2003 Apr; 26(3):301-6. PubMed ID: 12637079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS.
    Baldanti F; Underwood MR; Stanat SC; Biron KK; Chou S; Sarasini A; Silini E; Gerna G
    J Virol; 1996 Mar; 70(3):1390-5. PubMed ID: 8627655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different mutations in the HHV-6 DNA polymerase gene accounting for resistance to foscarnet.
    Bonnafous P; Naesens L; Petrella S; Gautheret-Dejean A; Boutolleau D; Sougakoff W; Agut H
    Antivir Ther; 2007; 12(6):877-88. PubMed ID: 17926642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential impact of various substitutions at codon 715 in region II of HSV-1 and HCMV DNA polymerases.
    Zarrouk K; Zhu X; Goyette N; Piret J; Shi R; Boivin G
    Antiviral Res; 2021 Apr; 188():105046. PubMed ID: 33588012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity.
    Mousavi-Jazi M; Schloss L; Drew WL; Linde A; Miner RC; Harmenberg J; Wahren B; Brytting M
    J Clin Virol; 2001 Dec; 23(1-2):1-15. PubMed ID: 11595579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residues of human cytomegalovirus DNA polymerase catalytic subunit UL54 that are necessary and sufficient for interaction with the accessory protein UL44.
    Loregian A; Appleton BA; Hogle JM; Coen DM
    J Virol; 2004 Jan; 78(1):158-67. PubMed ID: 14671097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.
    Loregian A; Rigatti R; Murphy M; Schievano E; Palu G; Marsden HS
    J Virol; 2003 Aug; 77(15):8336-44. PubMed ID: 12857903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the cytomegalovirus DNA polymerase subunit UL44 in complex with the C terminus from the catalytic subunit. Differences in structure and function relative to unliganded UL44.
    Appleton BA; Brooks J; Loregian A; Filman DJ; Coen DM; Hogle JM
    J Biol Chem; 2006 Feb; 281(8):5224-32. PubMed ID: 16371349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapy.
    Chou S
    J Clin Virol; 2011 Apr; 50(4):287-91. PubMed ID: 21295516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a non-radioactive DNA polymerase assay for studying cytomegalovirus resistance to foscarnet.
    Ducancelle A; Alain S; Petit F; Sanson Le Pors MJ; Mazeron MC
    J Virol Methods; 2007 May; 141(2):212-5. PubMed ID: 17197042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpesvirus DNA polymerases: Structures, functions and inhibitors.
    Zarrouk K; Piret J; Boivin G
    Virus Res; 2017 Apr; 234():177-192. PubMed ID: 28153606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific residues in the connector loop of the human cytomegalovirus DNA polymerase accessory protein UL44 are crucial for interaction with the UL54 catalytic subunit.
    Loregian A; Appleton BA; Hogle JM; Coen DM
    J Virol; 2004 Sep; 78(17):9084-92. PubMed ID: 15308704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting effect of new HCMV pUL54 mutations on antiviral drug susceptibility: Benefits and limits of 3D analysis.
    Andouard D; Mazeron MC; Ligat G; Couvreux A; Pouteil-Noble C; Cahen R; Yasdanpanah Y; Deering M; Viget N; Alain S; Hantz S
    Antiviral Res; 2016 May; 129():115-119. PubMed ID: 26872863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of coexisting HCMV-UL97 and UL54 drug-resistance associated mutations in patients after haematopoietic cell transplantation.
    Göhring K; Wolf D; Bethge W; Mikeler E; Faul C; Vogel W; Vöhringer MC; Jahn G; Hamprecht K
    J Clin Virol; 2013 May; 57(1):43-9. PubMed ID: 23375740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.